Cargando…
AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials
In phase I cancer clinical trials, the maximum tolerated dose of a new drug is often found by a dose-escalation method known as the A + B design. We have developed an interactive web application, AplusB, which computes and returns exact operating characteristics of A + B trial designs. The applicati...
Autores principales: | Wheeler, Graham M., Sweeting, Michael J., Mander, Adrian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942070/ https://www.ncbi.nlm.nih.gov/pubmed/27403961 http://dx.doi.org/10.1371/journal.pone.0159026 |
Ejemplares similares
-
A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
por: Wheeler, Graham, et al.
Publicado: (2015) -
Toxicity‐dependent feasibility bounds for the escalation with overdose control approach in phase I cancer trials
por: Wheeler, Graham M., et al.
Publicado: (2017) -
A product of independent beta probabilities dose escalation design for dual-agent phase I trials
por: Mander, Adrian P, et al.
Publicado: (2015) -
Escalation strategies for combination therapy Phase I trials
por: Sweeting, Michael J, et al.
Publicado: (2012) -
APLUS: A Python library for usefulness simulations of machine learning models in healthcare
por: Wornow, Michael, et al.
Publicado: (2023)